Publication Name	World Journal of Gastrointestinal Endoscopy
Manuscript ID	98548
Country	Spain

Received	2024-06-28 19:23
Peer-Review Started	2024-06-28 19:23
To Make the First Decision
Return for Revision	2024-08-04 07:04
Revised	2024-08-08 21:55
Second Decision	2024-08-20 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-08-20 08:58
Articles in Press	2024-08-20 08:58
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-08-27 12:02
Typeset the Manuscript	2024-08-30 02:11
Publish the Manuscript Online	2024-09-12 03:29

ISSN	1948-5190 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	How secure can we expect the surveillance policies to be after the implementation in T1 polyps with carcinoma?
Manuscript Source	Invited Manuscript
All Author List	Cristina Mateos Sanchez, Elvira Quintanilla Lazaro and Luis Ramon Rabago
Funding Agency and Grant Number
Corresponding Author	Luis Ramon Rabago, MD, PhD, Chief Physician, Department of Gastroenterology, San Rafael Hospital, Street Serrano 199, Madrid 28016, Spain. lrabagot@gmail.com
Key Words	pT1 adenocarcinoma polyps; pT1 follow up management; Histological recurrence rate of pT1 adenocarcinoma; Endoscopic and histologic poor prognostic criteria
Core Tip	The management of endoscopically benign polyps that histopathologically prove to contain pT1 adenocarcinoma is not defined, pending international definition of the required resection and histological criteria to be able to rely on a follow-up without surgery. Based on Fabian's study, it is very likely that the rate of complete resection and the risk of recurrence is much higher than previously published and that we must also consider the risk of insufficient therapy. The follow-up of these patients remains to be clarified and agreed upon in multicenter studies that will make it possible to obtain more data at least for clinical practice and, above all, to insist on the potential risk for survival when patients are lost in follow-up programs.
Publish Date	2024-09-12 03:29
Citation	<p>Mateos Sanchez C, Quintanilla Lazaro E, Rabago LR. How secure can we expect the surveillance policies to be after the implementation in T1 polyps with carcinoma? <i>World J Gastrointest Endosc</i> 2024; 16(9): 502-508</p>
URL	https://www.wjgnet.com/1948-5190/full/v16/i9/502.htm
DOI	https://dx.doi.org/10.4253/wjge.v16.i9.502

Full Article (PDF)	WJGE-16-502-with-cover.pdf
Manuscript File	98548_Auto_Edited_030407.docx
Answering Reviewers	98548-answering-reviewers.pdf
Audio Core Tip	98548-audio.m4a
Conflict-of-Interest Disclosure Form	98548-conflict-of-interest-statement.pdf
Copyright License Agreement	98548-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	98548-non-native-speakers.pdf
Peer-review Report	98548-peer-reviews.pdf
Scientific Misconduct Check	98548-scientific-misconduct-check.png
Scientific Editor Work List	98548-scientific-editor-work-list.pdf
CrossCheck Report	98548-crosscheck-report.pdf